Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India-Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity.

N-Desmethylclozapine, Fluoxetine and Salmeterol inhibit post-entry stages of dengue virus life-cycle. Antimicrob Agents Chemother (2016) 0.79

Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults. BMC Infect Dis (2016) 0.77

Correction: Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India-Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity. PLoS Negl Trop Dis (2016) 0.77

Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection. J Virol (2016) 0.75

Mathematical modelling and a systems science approach to describe the role of cytokines in the evolution of severe dengue. BMC Syst Biol (2017) 0.75

Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol (2016) 0.75

Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials. PLoS Negl Trop Dis (2016) 0.75

Meta-analysis of biomarkers for severe dengue infections. PeerJ (2017) 0.75

Dengue Virus Entry and Replication Does Not Lead to Productive Infection in Platelets. Open Forum Infect Dis (2017) 0.75

The global distribution and burden of dengue. Nature (2013) 27.92

Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol (1992) 17.82

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44

Interleukin-10 determines viral clearance or persistence in vivo. Nat Med (2006) 8.01

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci U S A (1993) 6.12

IL-10: the master regulator of immunity to infection. J Immunol (2008) 6.11

Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis (2002) 4.67

Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis (2004) 3.68

Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol (2011) 3.62

Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet (2007) 3.52

Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg (1999) 3.11

A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model. PLoS Med (2009) 2.59

Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis (2004) 2.43

Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg (2006) 2.39

Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation (2002) 2.28

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis (2010) 2.24

Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis (2008) 2.08

Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol (2006) 2.07

Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol (2000) 2.02

Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis (2006) 1.99

Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol (2000) 1.88

Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol (1999) 1.79

High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology (2003) 1.79

IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol (2004) 1.77

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology (2008) 1.54

IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol (2004) 1.50

Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol (1998) 1.49

Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam. PLoS Negl Trop Dis (2011) 1.29

IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin Immunol (2012) 1.27

Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol (2005) 1.26

Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol (2002) 1.25

Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol (2001) 1.24

Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One (2010) 1.23

Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe (2014) 1.22

Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost (2013) 1.21

Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. J Infect Dis (2011) 1.08

Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol (2005) 1.08

Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood (2002) 1.02

Infection of bone marrow cells by dengue virus in vivo. Exp Hematol (2011) 1.02

Cytokine patterns during dengue shock syndrome. Eur Cytokine Netw (2003) 1.01

Serum IL-10 as a marker of severe dengue infection. BMC Infect Dis (2013) 1.00

Suppression of virus specific immune responses by IL-10 in acute dengue infection. PLoS Negl Trop Dis (2013) 0.99

Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunol Med Microbiol (2006) 0.98

Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication. PLoS Pathog (2014) 0.96

Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice. J Virol (2013) 0.96

Robustness of Random Forest-based gene selection methods. BMC Bioinformatics (2014) 0.94

Economic and disease burden of dengue illness in India. Am J Trop Med Hyg (2014) 0.93

Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One (2010) 0.92

Adaptor protein complexes-1 and 3 are involved at distinct stages of flavivirus life-cycle. Sci Rep (2013) 0.91

Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar. J Med Virol (2013) 0.89

Downregulation of interferon-β in antibody-dependent enhancement of dengue viral infections of human macrophages is dependent on interleukin-6. J Infect Dis (2011) 0.83

Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models. Curr Opin Virol (2015) 0.83

Immunopathogenesis of dengue hemorrhagic fever: contribution to the study of human liver lesions. J Med Virol (2013) 0.82

The association of cytokines with severe dengue in children. Trop Med Health (2014) 0.82

Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in Malaysia. PLoS One (2014) 0.81

Vitamin D levels in Indian children with intrathoracic tuberculosis. Indian J Med Res (2014) 2.07

Clinical profile and natural history of children with HIV infection. Indian J Pediatr (2006) 1.58

COVID-19 Pandemic: The Way Forward. Indian J Pediatr (2020) 1.38

Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study. Lancet Infect Dis (2021) 1.38

Newer diagnostic modalities for tuberculosis. Indian J Pediatr (2004) 0.82

Full outline of unresponsiveness score versus Glasgow Coma Scale in children with nontraumatic impairment of consciousness. J Child Neurol (2014) 0.80

Assessing the impact of an educational intervention on ventilator-associated pneumonia in a pediatric critical care unit. Am J Infect Control (2014) 0.78

Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum. Sci Rep (2016) 0.77

Langerhans cell histiocytosis in a pediatric HIV patient. Virusdisease (2015) 0.75

BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome. Sci Rep (2016) 0.75

Brocho-biliary fistula: A rare complication after ruptured liver abscess in a 3½ year old child. Lung India (2015) 0.75

Burden Among Caregivers of Children Living with Human Immunodeficiency Virus in North India. N Am J Med Sci (2016) 0.75

Predictors of time to recovery in infants with probable serious bacterial infection. PLoS One (2015) 0.75

Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children. Sci Rep (2017) 0.75

Cystic fibrosis in low and middle-income countries (LMIC): A view from four different regions of the world. Paediatr Respir Rev (2020) 0.75

Prevalence and Risk Factors of Allergic Bronchopulmonary Aspergillosis and Aspergillus Sensitization in Children with Poorly Controlled Asthma. J Trop Pediatr (2019) 0.75

CD4-Binding Site Directed Cross-Neutralizing scFv Monoclonals from HIV-1 Subtype C Infected Indian Children. Front Immunol (2017) 0.75

Primary Immunodeficiency Disorders Among North Indian Children. Indian J Pediatr (2019) 0.75

A Randomized Controlled Trial of 2 Inhalation Methods When Using a Pressurized Metered Dose Inhaler With Valved Holding Chamber. Respir Care (2015) 0.75

Unusual late neurological complication in a child after an Indian krait bite. Pediatr Neurol (2014) 0.75